ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

March 25, 1983

NIC Grants Appeals Process Explained

April 19, 1985

Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws

November 20, 1992

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Also Lance Armstrong visits NIH, Washington, for Tour of Hope event.

October 17, 2003

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981